Journal article
Counterpoint: Low-Density Lipoprotein Cholesterol Targets Are Not Needed in Lipid Treatment Guidelines
Arteriosclerosis, thrombosis, and vascular biology, Vol.36(4), pp.586-590
04/2016
DOI: 10.1161/ATVBAHA.116.306887
PMID: 26988588
Abstract
On the basis of accumulating evidence, low-density lipoprotein cholesterol (LDL-C) treat-to-goal approaches no longer seem to be the best way to optimize lipid-modifying therapy to prevent atherosclerotic cardiovascular disease (ASCVD). The potential for a net ASCVD risk reduction benefit is a more individualized approach to clinical decision making and may better inform patient preferences. However, risk estimation tools will need to be developed to facilitate more personalized CVD risk estimation in statin-treated patients. In the meantime, LDL-C thresholds rather than targets may aid in determining which patients might benefit from additional LDL-C-lowering therapy beyond statins.
Details
- Title: Subtitle
- Counterpoint: Low-Density Lipoprotein Cholesterol Targets Are Not Needed in Lipid Treatment Guidelines
- Creators
- Jennifer G Robinson - University of Iowa, EpidemiologyKausik Ray - Imperial College London
- Resource Type
- Journal article
- Publication Details
- Arteriosclerosis, thrombosis, and vascular biology, Vol.36(4), pp.586-590
- Publisher
- United States
- DOI
- 10.1161/ATVBAHA.116.306887
- PMID
- 26988588
- ISSN
- 1079-5642
- eISSN
- 1524-4636
- Language
- English
- Date published
- 04/2016
- Academic Unit
- Epidemiology; Internal Medicine
- Record Identifier
- 9983995005502771
Metrics
16 Record Views